Application 062001
- Type
- ANDA
- Sponsor
- PARKE DAVIS
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | PENAPAR-VK | PENICILLIN V POTASSIUM | TABLET;ORAL | EQ 250MG BASE | No | No |
| 002 | PENAPAR-VK | PENICILLIN V POTASSIUM | TABLET;ORAL | EQ 500MG BASE | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A062001-001 | PENAPAR-VK | PENICILLIN V POTASSIUM | EQ 250MG BASE | TABLET / ORAL | Approved before 1982 | ||
| A062001-002 | PENAPAR-VK | PENICILLIN V POTASSIUM | EQ 500MG BASE | TABLET / ORAL | Approved before 1982 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2022-03-09 01:35 UTC | 2022-03 | A062001-001 | PENAPAR-VK | EQ 250MG BASE | TABLET / ORAL | Approved before 1982 | bb7c543d1eb4… | ||
| 2022-03-09 01:35 UTC | 2022-03 | A062001-002 | PENAPAR-VK | EQ 500MG BASE | TABLET / ORAL | Approved before 1982 | bb7c543d1eb4… | ||
| 2021-12-28 21:50 UTC | 2021-12 | A062001-001 | PENAPAR-VK | EQ 250MG BASE | TABLET / ORAL | Approved before 1982 | 782e0a99824c… | ||
| 2021-12-28 21:50 UTC | 2021-12 | A062001-002 | PENAPAR-VK | EQ 500MG BASE | TABLET / ORAL | Approved before 1982 | 782e0a99824c… | ||
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | A062001-001 | PENAPAR-VK | EQ 250MG BASE | TABLET / ORAL | Approved before 1982 | 87673890dc5c… | ||
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | A062001-002 | PENAPAR-VK | EQ 500MG BASE | TABLET / ORAL | Approved before 1982 | 87673890dc5c… | ||
| 2021-03-12 10:30 UTC | 2021-03 | A062001-001 | PENAPAR-VK | EQ 250MG BASE | TABLET / ORAL | Approved before 1982 | 5aa47cf7b7d7… | ||
| 2021-03-12 10:30 UTC | 2021-03 | A062001-002 | PENAPAR-VK | EQ 500MG BASE | TABLET / ORAL | Approved before 1982 | 5aa47cf7b7d7… | ||
| 2020-12-22 03:56 UTC | 2020-12 | A062001-001 | PENAPAR-VK | EQ 250MG BASE | TABLET / ORAL | Approved before 1982 | 8869cabd3fbd… | ||
| 2020-12-22 03:56 UTC | 2020-12 | A062001-002 | PENAPAR-VK | EQ 500MG BASE | TABLET / ORAL | Approved before 1982 | 8869cabd3fbd… | ||
| 2020-11-12 02:37 UTC | 2020-11 | A062001-001 | PENAPAR-VK | EQ 250MG BASE | TABLET / ORAL | Approved before 1982 | c0c555d07b60… | ||
| 2020-11-12 02:37 UTC | 2020-11 | A062001-002 | PENAPAR-VK | EQ 500MG BASE | TABLET / ORAL | Approved before 1982 | c0c555d07b60… | ||
| 2019-12-14 00:12 UTC | 2019-12 | A062001-001 | PENAPAR-VK | EQ 250MG BASE | TABLET / ORAL | Approved before 1982 | 3f01610625f2… | ||
| 2019-12-14 00:12 UTC | 2019-12 | A062001-002 | PENAPAR-VK | EQ 500MG BASE | TABLET / ORAL | Approved before 1982 | 3f01610625f2… | ||
| 2019-09-15 20:21 UTC | 2019-09 | A062001-001 | PENAPAR-VK | EQ 250MG BASE | TABLET / ORAL | Approved before 1982 | b00525d2431f… | ||
| 2019-09-15 20:21 UTC | 2019-09 | A062001-002 | PENAPAR-VK | EQ 500MG BASE | TABLET / ORAL | Approved before 1982 | b00525d2431f… | ||
| 2019-07-19 19:46 UTC | 2019-07 | A062001-001 | PENAPAR-VK | EQ 250MG BASE | TABLET / ORAL | Approved before 1982 | ea99ee380514… | ||
| 2019-07-19 19:46 UTC | 2019-07 | A062001-002 | PENAPAR-VK | EQ 500MG BASE | TABLET / ORAL | Approved before 1982 | ea99ee380514… | ||
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | A062001-001 | PENAPAR-VK | EQ 250MG BASE | TABLET / ORAL | Approved before 1982 | 6a51e52b5d6a… | ||
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | A062001-002 | PENAPAR-VK | EQ 500MG BASE | TABLET / ORAL | Approved before 1982 | 6a51e52b5d6a… | ||
| 2024-02-18 07:12 UTC | 2024-02 | A062001-001 | PENAPAR-VK | EQ 250MG BASE | TABLET / ORAL | Approved before 1982 | 1c564ffb4f44… | ||
| 2024-02-18 07:12 UTC | 2024-02 | A062001-002 | PENAPAR-VK | EQ 500MG BASE | TABLET / ORAL | Approved before 1982 | 1c564ffb4f44… | ||
| 2023-12-20 04:57 UTC | 2023-12 | A062001-001 | PENAPAR-VK | EQ 250MG BASE | TABLET / ORAL | Approved before 1982 | ea1830bbd6c7… | ||
| 2023-12-20 04:57 UTC | 2023-12 | A062001-002 | PENAPAR-VK | EQ 500MG BASE | TABLET / ORAL | Approved before 1982 | ea1830bbd6c7… | ||
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | A062001-001 | PENAPAR-VK | EQ 250MG BASE | TABLET / ORAL | Approved before 1982 | a72a2bbeb626… | ||
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | A062001-002 | PENAPAR-VK | EQ 500MG BASE | TABLET / ORAL | Approved before 1982 | a72a2bbeb626… | ||
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | A062001-001 | PENAPAR-VK | EQ 250MG BASE | TABLET / ORAL | Approved before 1982 | 9b2671bbb829… | ||
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | A062001-002 | PENAPAR-VK | EQ 500MG BASE | TABLET / ORAL | Approved before 1982 | 9b2671bbb829… | ||
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | A062001-001 | PENAPAR-VK | EQ 250MG BASE | TABLET / ORAL | Approved before 1982 | a67488948f0b… | ||
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | A062001-002 | PENAPAR-VK | EQ 500MG BASE | TABLET / ORAL | Approved before 1982 | a67488948f0b… | ||
| 2023-06-13 01:57 UTC · 3 captures of this ZIP | 2023-06 | A062001-001 | PENAPAR-VK | EQ 250MG BASE | TABLET / ORAL | Approved before 1982 | 3f0d92c62455… | ||
| 2023-06-13 01:57 UTC · 3 captures of this ZIP | 2023-06 | A062001-002 | PENAPAR-VK | EQ 500MG BASE | TABLET / ORAL | Approved before 1982 | 3f0d92c62455… | ||
| 2023-05-13 08:27 UTC | 2023-05 | A062001-001 | PENAPAR-VK | EQ 250MG BASE | TABLET / ORAL | Approved before 1982 | 053a50430f4f… | ||
| 2023-05-13 08:27 UTC | 2023-05 | A062001-002 | PENAPAR-VK | EQ 500MG BASE | TABLET / ORAL | Approved before 1982 | 053a50430f4f… | ||
| 2023-01-26 05:58 UTC | 2023-01 | A062001-001 | PENAPAR-VK | EQ 250MG BASE | TABLET / ORAL | Approved before 1982 | 3bdfa0b2c4d7… | ||
| 2023-01-26 05:58 UTC | 2023-01 | A062001-002 | PENAPAR-VK | EQ 500MG BASE | TABLET / ORAL | Approved before 1982 | 3bdfa0b2c4d7… | ||
| 2022-11-12 20:34 UTC · 5 captures of this ZIP | 2022-11 | A062001-001 | PENAPAR-VK | EQ 250MG BASE | TABLET / ORAL | Approved before 1982 | 3a93d1ddd44b… | ||
| 2022-11-12 20:34 UTC · 5 captures of this ZIP | 2022-11 | A062001-002 | PENAPAR-VK | EQ 500MG BASE | TABLET / ORAL | Approved before 1982 | 3a93d1ddd44b… | ||
| 2022-10-28 04:53 UTC | 2022-10 | A062001-001 | PENAPAR-VK | EQ 250MG BASE | TABLET / ORAL | Approved before 1982 | f41ea6bd6efb… | ||
| 2022-10-28 04:53 UTC | 2022-10 | A062001-002 | PENAPAR-VK | EQ 500MG BASE | TABLET / ORAL | Approved before 1982 | f41ea6bd6efb… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Penicillin V Potassium | PENICILLIN V POTASSIUM | REMEDYREPACK INC. | dd8a48b2-9ff1-49de-a53e-db4964c2384c | 2026-09-03 | Warnings, Adverse reactions | PENICILLIN V POTASSIUM |
| Penicillin V Potassium | PENICILLIN V POTASSIUM | NuCare Pharmaceuticals,Inc. | 861ccfaa-8b7a-0def-e053-2991aa0a1a39 | 2026-08-21 | Warnings, Adverse reactions | PENICILLIN V POTASSIUM |
| Penicillin V Potassium | PENICILLIN V POTASSIUM | Redpharm Drug | 58e6fd2f-e595-f788-e063-6394a90a0ea2 | 2026-08-13 | Warnings, Adverse reactions | PENICILLIN V POTASSIUM |
| Penicillin V Potassium | PENICILLIN V POTASSIUM | Preferred Pharmaceuticals, Inc | 8c342c78-47fb-4f6b-9451-68b1f752555c | 2026-08-12 | Warnings, Adverse reactions | PENICILLIN V POTASSIUM |
| Penicillin V Potassium | PENICILLIN V POTASSIUM | Preferred Pharmaceuticals Inc. | 56192625-0564-4131-94b2-8b9c6a0b53b0 | 2026-08-12 | Warnings, Adverse reactions | PENICILLIN V POTASSIUM |
| Penicillin V Potassium | PENICILLIN V POTASSIUM | REMEDYREPACK INC. | 5f0759cc-c553-49b9-9049-80e713758958 | 2026-08-07 | Warnings, Adverse reactions | PENICILLIN V POTASSIUM |
| Penicillin V Potassium | PENICILLIN V POTASSIUM | REMEDYREPACK INC. | fba1ffe5-809a-495b-bf3e-f2099ac459f6 | 2026-07-28 | Warnings, Adverse reactions | PENICILLIN V POTASSIUM |
| Penicillin V Potassium | PENICILLIN V POTASSIUM | REMEDYREPACK INC. | 8f9fa2c8-4d25-48a8-9257-43c33d08e83a | 2026-07-28 | Warnings, Adverse reactions | PENICILLIN V POTASSIUM |
| Penicillin V Potassium | PENICILLIN V POTASSIUM | REMEDYREPACK INC. | b5972712-f735-46ed-a94a-b84668bb6a82 | 2026-07-24 | Warnings, Adverse reactions | PENICILLIN V POTASSIUM |
| Penicillin V Potassium | PENICILLIN V POTASSIUM | Chartwell RX, LLC | b0744674-ddf7-4022-be2f-2a22bef0d379 | 2026-07-23 | Warnings, Adverse reactions | PENICILLIN V POTASSIUM |
| Penicillin V Potassium | PENICILLIN V POTASSIUM | Redpharm Drug | 546c367a-c786-8326-e063-6294a90ae76c | 2026-07-14 | Warnings, Adverse reactions | PENICILLIN V POTASSIUM |
| Penicillin V Potassium | PENICILLIN V POTASSIUM | Proficient Rx LP | b8f797fb-979c-4eab-a3a6-ad4edcb9ff07 | 2026-06-01 | Warnings, Adverse reactions | PENICILLIN V POTASSIUM |
| Penicillin V Potassium | PENICILLIN V POTASSIUM | Bryant Ranch Prepack | 609c3e26-9220-4f3c-b393-a2b41b68de6c | 2026-03-12 | Warnings, Adverse reactions | PENICILLIN V POTASSIUM |
| Penicillin V Potassium | PENICILLIN V POTASSIUM | QPharma Inc | 8c11af69-146f-47ed-b12a-7b201fec7e50 | 2025-12-04 | Warnings, Adverse reactions | PENICILLIN V POTASSIUM |
| Penicillin V Potassium | PENICILLIN V POTASSIUM | PD-Rx Pharmaceuticals, Inc. | ceddc406-4a17-471f-917e-63b4b03779ea | 2025-10-17 | Warnings, Adverse reactions | PENICILLIN V POTASSIUM |
| Penicillin V Potassium | PENICILLIN V POTASSIUM | PD-Rx Pharmaceuticals, Inc. | 9bc7006d-a482-47c4-a138-5380ce927812 | 2025-10-16 | Warnings, Adverse reactions | PENICILLIN V POTASSIUM |
| Penicillin V Potassium | PENICILLIN V POTASSIUM | PD-Rx Pharmaceuticals, Inc. | 4ad879d4-eb32-49f0-af73-c47fc7581936 | 2025-10-15 | Warnings, Adverse reactions | PENICILLIN V POTASSIUM |
| Penicillin V Potassium | PENICILLIN V POTASSIUM | PD-Rx Pharmaceuticals, Inc. | 450ad3aa-7c9e-497b-b00e-b1af0322f8d0 | 2025-10-15 | Warnings, Adverse reactions | PENICILLIN V POTASSIUM |
| Penicillin V Potassium | PENICILLIN V POTASSIUM | PD-Rx Pharmaceuticals, Inc. | 0151c742-7525-4707-af03-bd48d50cd586 | 2025-10-15 | Warnings, Adverse reactions | PENICILLIN V POTASSIUM |
| Penicillin V Potassium | PENICILLIN V POTASSIUM | PD-Rx Pharmaceuticals, Inc. | 281f9c32-e28a-46ae-9e4e-c2143aaa6c6b | 2025-10-15 | Warnings, Adverse reactions | PENICILLIN V POTASSIUM |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.